Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240)
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 7 (1) , 63-66
- https://doi.org/10.1007/bf01962177
Abstract
RO 23-6240 (fleroxacin), pefloxacin, augmentin, cefaclor, cef-uroxime, ceftazidime, vancomycin, piperacillin and amikacin were tested against a wide variety of gram-positive and gram-negative bacteria. The MICs of fleroxacin were very similar to those of pefloxacin. Against all the bacterial groups tested, the quinolones compared favorably with the other antimicrobials tested, particularly against the more resistant species such asCorynebacterium group JK and D2 and methicillin-resistant staphylococci.Keywords
This publication has 8 references indexed in Scilit:
- In vitro activity of the new 4-quinolone compound RO 23-6240European Journal of Clinical Microbiology & Infectious Diseases, 1987
- Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinoloneAntimicrobial Agents and Chemotherapy, 1987
- Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteriaAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneAntimicrobial Agents and Chemotherapy, 1986
- In-vitro activity of pefloxacin against micro-organisms multiply resistant to -lactam antibiotics and aminoglycosidesJournal of Antimicrobial Chemotherapy, 1986
- The comparative in-vitro activity of pefloxacinJournal of Antimicrobial Chemotherapy, 1986
- The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acidJournal of Antimicrobial Chemotherapy, 1984